The global ophthalmic viscosurgical devices (OVD) market size was USD 522.23 million in 2023, calculated at USD 543.28 million in 2024 and is expected to be worth around USD 806.50 million by 2034. The market is slated to expand at 4.03% CAGR from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Ophthalmic Viscosurgical Devices (OVD) Market
5.1. COVID-19 Landscape: Ophthalmic Viscosurgical Devices (OVD) Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Ophthalmic Viscosurgical Devices (OVD) Market, By Type
8.1. Ophthalmic Viscosurgical Devices (OVD) Market Revenue and Volume, by Type, 2024-2034
8.1.1 Dispersive
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Cohesive
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Viscoadaptive
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Ophthalmic Viscosurgical Devices (OVD) Market, By Source
9.1. Ophthalmic Viscosurgical Devices (OVD) Market Revenue and Volume, by Source, 2024-2034
9.1.1. Animal
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Biological
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Semi-synthetic
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Ophthalmic Viscosurgical Devices (OVD) Market, By Application
10.1. Ophthalmic Viscosurgical Devices (OVD) Market Revenue and Volume, by Application, 2024-2034
10.1.1. Cataract Surgery
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Glaucoma Surgery
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Corneal Grafting
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Vitreoretinal Surgery
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 11. Global Ophthalmic Viscosurgical Devices (OVD) Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Source (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
Chapter 12. Company Profiles
12.1. Carl Zeiss Meditec AG
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Alcon AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Beaver-Visitec International, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Amring Pharmaceutical Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Rayner Intraocular Lenses Limited
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Bohus Biotech AB
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Johnson & Johnson Services, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample